Biomarker detection system

US11719632B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11719632-B2
Application numberUS-201716318946-A
CountryUS
Kind codeB2
Filing dateJul 21, 2017
Priority dateJul 21, 2016
Publication dateAug 8, 2023
Grant dateAug 8, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed is a localised surface plasmon resonance (LSPR) nanopillar assembly. The LSPR assembly is for use in sensing the presence of a biomarker when attached to a quantum dot. The LSPR assembly comprises a substrate and an array. The array comprises a LSPR nanopillar and a polymer spacer attached to the nanopillar. The LSPR assembly further comprises an antibody attached to the at least one polymer spacer. In the LSPR assembly, a combined height of the polymer spacer and antibody is selected by varying the number of monomer units of the polymer spacer, so that, when in use with the biomarker and the quantum dot, the quantum dot is at a predetermined distance from the nanopillar.

First claim

Opening claim text (preview).

The invention claimed is: 1. A localised surface plasmon resonance (LSPR) nanopillar assembly for use in sensing the presence of a biomarker when attached to a quantum dot, comprising: a) a substrate; b) an array comprising: i) a plurality of metallic LSPR nanopillars, each of the nanopillars consists of a metallic nanopillar body; and ii) at least one polymer spacer attached to the nanopillars; and c) an antibody attached to the at least one polymer spacer; wherein a combined height of the polymer spacer and antibody is such that, when in use with the biomarker and the quantum dot, the quantum dot is in an LSPR region of the nanopillar; and each of the at least one polymer spacer comprises a discrete linear or non-linear polymer molecule having at least two opposed terminal ends, a first terminal end being attached to the nanopillar and a second spaced and opposed terminal end being attached to the antibody; wherein the polymer spacer is a polyethylene glycol (PEG) spacer; wherein the PEG spacer is PEG 2-100 ; wherein the metallic nanopillar body has a length of about 50 nm to about 250 nm, width of about 50 nm to about 250 nm, and height of about 20 nm to about 100 nm; wherein the nanopillar array comprises a plurality of metallic nanopillars, in which a pitch of the nanopillar array is about 150 nm to about 500 nm. 2. The LSPR nanopillar assembly of claim 1 , wherein the polymer spacer is conjugated to the metallic nanopillar body and the antibody is conjugated to the polymer spacer. 3. The LSPR nanopillar assembly of claim 1 , wherein the polymer spacer is maintained in a substantially upright position relative to a surface of the substrate to sense the presence of the biomarker when attached to the quantum dot. 4. The LSPR nanopillar assembly of claim 1 , wherein the polymer spacer is conjugated to the nanopillar by a sulphide bond. 5. The LSPR nanopillar assembly of claim 1 , wherein the PEG spacer is PEG 7 . 6. The LSPR nanopillar assembly of claim 1 , wherein the metallic nanopillar body has a length of about 140 nm, width of about 140 nm, and height of about 55 nm. 7. The LSPR nanopillar assembly of claim 1 , wherein the pitch of the metallic nanopillar array is about 320 nm. 8. The LSPR nanopillar assembly of claim 1 , wherein the metallic nanopillar body is substantially wholly made of gold or silver.

Assignees

Inventors

Classifications

  • G01N21/554Primary

    detecting the surface plasmon resonance of nanostructured metals, e.g. localised surface plasmon resonance · CPC title

  • Arrangements or apparatus for facilitating the optical investigation · CPC title

  • using evanescent coupling or surface plasmon coupling for the excitation of fluorescence · CPC title

  • with ligand attached to the carrier via a chemical coupling agent (coatings G01N33/54393) · CPC title

  • involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11719632B2 cover?
Disclosed is a localised surface plasmon resonance (LSPR) nanopillar assembly. The LSPR assembly is for use in sensing the presence of a biomarker when attached to a quantum dot. The LSPR assembly comprises a substrate and an array. The array comprises a LSPR nanopillar and a polymer spacer attached to the nanopillar. The LSPR assembly further comprises an antibody attached to the at least one …
Who is the assignee on this patent?
Temasek Polytechnic, Agency Science Tech & Res, Tan Tock Seng Hospital Pte Ltd
What technology area does this patent fall under?
Primary CPC classification G01N21/554. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Aug 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).